{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:31:39Z","timestamp":1780680699146,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T00:00:00Z","timestamp":1703894400000},"content-version":"vor","delay-in-days":577,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Particle Therapy"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.14338\/ijpt-21-00042.1","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T11:55:33Z","timestamp":1655121333000},"page":"42-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of Estimated Late Toxicities between IMPT and IMRT Based on Multivariable NTCP Models for High-Risk Prostate Cancers Treated with Pelvic Nodal Radiation"],"prefix":"10.1016","volume":"9","author":[{"given":"Srinivas","family":"Chilukuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sham","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartikeswar","family":"Patro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rangasamy","family":"Sivaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manikandan","family":"Arjunan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj Kumar","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayananda","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.14338\/IJPT-21-00042.1_bib1","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1200\/JCO.21.00621","article-title":"Elective pelvic lymph node radiation in prostate cancer revisited","volume":"39","author":"Yang","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-21-00042.1_bib2","author":"National Comprehensive Cancer Network.","year":"2021","journal-title":"Prostate. Version 2.2021. Accessed June 17, 2021."},{"key":"10.14338\/IJPT-21-00042.1_bib3","author":"European Association of Urology.","year":"2021","journal-title":"EAU Guidelines: Prostate Cancer. Accessed June 17"},{"issue":"11","key":"10.14338\/IJPT-21-00042.1_bib4","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.20.03282","article-title":"Prostate-only versus whole-pelvic radiation therapy in high-risk and very high-risk prostate cancer (POP-RT): outcomes from phase III randomized controlled trial","volume":"39","author":"Murthy","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-21-00042.1_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.radonc.2019.12.006","article-title":"Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high-risk prostate cancer (POP-RT): a randomised trial","volume":"145","author":"Murthy","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.14338\/IJPT-21-00042.1_bib6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ijrobp.2018.10.003","article-title":"Toxicity and patient-reported outcomes of a phase 2 randomized trial of prostate and pelvic lymph node versus prostate only radiotherapy in advanced localised prostate cancer (PIVOTAL)","volume":"103","author":"Dearnaley","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.14338\/IJPT-21-00042.1_bib7","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijrobp.2020.01.003","article-title":"Derivation of dose\/volume constraints for the anorectum from clinician- and patient-reported outcomes in the CHHiP trial of radiation therapy fractionation","volume":"106","author":"Wilkins","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-21-00042.1_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.radonc.2016.04.005","article-title":"Normal tissue complication probability (NTCP) models for late rectal bleeding, stool frequency and fecal incontinence after radiotherapy in prostate cancer patients","volume":"119","author":"Schaake","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.14338\/IJPT-21-00042.1_bib9","article-title":"Development of a prediction model for late urinary incontinence, hematuria, pain and voiding frequency among irradiated prostate cancer patients. PLOS ONE.","author":"Schaake","year":"2018","journal-title":"13. Accessed June 17, 2021."},{"key":"10.14338\/IJPT-21-00042.1_bib10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41391-019-0140-7","article-title":"Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care","volume":"22","author":"Kamran","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.14338\/IJPT-21-00042.1_bib11","first-page":"67","article-title":"Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts","volume":"16","author":"Wisenbaugh","year":"2014","journal-title":"Rev Urol"},{"key":"10.14338\/IJPT-21-00042.1_bib12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijrobp.2007.03.018","article-title":"Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison","volume":"69","author":"Trofimov","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-21-00042.1_bib13","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ijrobp.2007.07.2335","article-title":"Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer","volume":"70","author":"Vargas","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-21-00042.1_bib14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ijrobp.2006.10.008","article-title":"Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment","volume":"67","author":"Zhang","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-21-00042.1_bib15","unstructured":"Efstathiou J., Prostate advanced radiation technologies investigating quality of life (PARTIQoL): a phase III randomized clinical trial of proton therapy vs IMRT for low or intermediate risk prostate cancer., ClinicalTrials.gov.identifier, : NCT01617161. Accessed June 15, 2021, https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01617161."},{"key":"10.14338\/IJPT-21-00042.1_bib16","unstructured":"A prospective comparative study of outcomes with proton and photon radiation in prostate cancer. University of Florida., ClinicalTrials.gov.identifier, : NCT03561220. Accessed June 15, 2021, https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03561220."},{"key":"10.14338\/IJPT-21-00042.1_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.14338\/IJPT-21-00042.1_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.semradonc.2017.11.008","article-title":"Clinical trial strategies to compare protons with photons","volume":"28","author":"Langendijk","year":"2018","journal-title":"Semin Radiat Oncol"},{"key":"10.14338\/IJPT-21-00042.1_bib19","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ijrobp.2011.08.007","article-title":"Dose-effect relationships for individual pelvic floor muscles and anorectal complaints after prostate radiotherapy","volume":"83","author":"Smeenk","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-21-00042.1_bib20","first-page":"76085","article-title":"Ultrasonographic assessment of bladder wall thickness in healthy Indian subpopulation","volume":"10","author":"Patil","year":"2018","journal-title":"Int J Curr Res"},{"key":"10.14338\/IJPT-21-00042.1_bib21","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1259\/bjr\/31372149","article-title":"21 years of biologically effective dose","volume":"83","author":"Fowler","year":"2010","journal-title":"Br J Radiol"},{"key":"10.14338\/IJPT-21-00042.1_bib22","author":"Haque","year":"2021","journal-title":"Toxicity of pelvic nodal radiation for localized prostate cancer. Ann Transl Med. 2019;7. Accessed June 17, 2021."},{"key":"10.14338\/IJPT-21-00042.1_bib23","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S1470-2045(18)30528-X","article-title":"Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG\/RTOG 9413): long-term results of a randomised, phase 3 trial","volume":"19","author":"Roach","year":"2018","journal-title":"Lancet Oncol"},{"issue":"34","key":"10.14338\/IJPT-21-00042.1_bib24","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1200\/JCO.2006.10.5171","article-title":"Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01","volume":"25","author":"Pommier","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-21-00042.1_bib25","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1200\/JCO.18.02237","article-title":"Treatment-related toxicity using prostate-only versus prostate and pelvic lymph node intensity-modulated radiation therapy: a national population-based study","volume":"37","author":"Parry","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-21-00042.1_bib26","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijrobp.2016.02.038","article-title":"Five-year biochemical results, toxicity, and patient-reported quality of life after delivery of dose-escalated image guided proton therapy for prostate cancer","volume":"95","author":"Bryant","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-21-00042.1_bib27","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.ijrobp.2009.01.044","article-title":"Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer","volume":"75","author":"Chera","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-21-00042.1_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.14338\/IJPT-18-00048.1","article-title":"IMPT versus VMAT for pelvic nodal irradiation in prostate cancer: a dosimetric comparison","volume":"5","author":"Whitaker","year":"2019","journal-title":"Int J Part Ther"},{"key":"10.14338\/IJPT-21-00042.1_bib29","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.ijrobp.2010.10.005","article-title":"Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis","volume":"80","author":"Widesott","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-21-00042.1_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7785\/tcrt.2012.500405","article-title":"Pelvic lymph node irradiation including pararectal sentinel nodes for prostate cancer patients: treatment optimization comparing intensity modulated x-rays, volumetric modulated arc therapy, and intensity modulated proton therapy","volume":"14","author":"Vees","year":"2015","journal-title":"Technol Cancer Res Treat"},{"key":"10.14338\/IJPT-21-00042.1_bib31","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00066-005-1317-7","article-title":"Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy","volume":"181","author":"Mock","year":"2005","journal-title":"Strahlenther Onkol"},{"key":"10.14338\/IJPT-21-00042.1_bib32","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00130404-200211000-00012","article-title":"The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: more than just a prostate gland immobilization device?","volume":"8","author":"Teh","year":"2002","journal-title":"Cancer J"},{"key":"10.14338\/IJPT-21-00042.1_bib33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ejmp.2016.03.003","article-title":"Predicting toxicity in radiotherapy for prostate cancer","volume":"32","author":"Landoni","year":"2016","journal-title":"Phys Med"},{"key":"10.14338\/IJPT-21-00042.1_bib34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.radonc.2020.10.025","article-title":"Multivariate normal tissue complication probability models for rectal and bladder morbidity in prostate cancer patients treated with proton therapy","volume":"153","author":"Pedersen","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.14338\/IJPT-21-00042.1_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2006.03.034","article-title":"Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling","volume":"66","author":"Peeters","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-21-00042.1_bib36","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.ijrobp.2007.07.017","article-title":"Fit of a generalized Lyman normal-tissue complication probability (NTCP) model to grade \u22652 late rectal toxicity data from patients treated on protocol RTOG 94-06","volume":"69","author":"Tucker","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-21-00042.1_bib37","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ijrobp.2006.10.014","article-title":"Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models","volume":"67","author":"S\u00f6hn","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-21-00042.1_bib38","doi-asserted-by":"crossref","first-page":"S332","DOI":"10.1016\/j.ijrobp.2008.06.1128","article-title":"Late rectal bleeding after conformal radiotherapy for prostate cancer: NTCP modeling [abstract]","volume":"72","author":"Fellin","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-21-00042.1_bib39","first-page":"7367","article-title":"Assessment of risk of late rectal bleeding for patients with prostate cancer started on anticoagulation before or after radiation treatment","volume":"34","author":"Schreiber","year":"2014","journal-title":"Anticancer Res"},{"key":"10.14338\/IJPT-21-00042.1_bib40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.prnil.2020.07.006","article-title":"Radiation-induced haemorrhagic cystitis after prostate cancer radiotherapy: factors associated to hospitalization and treatment strategies","volume":"9","author":"Sanguedolce","year":"2021","journal-title":"Prostate Int"},{"key":"10.14338\/IJPT-21-00042.1_bib41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.radonc.2020.07.056","article-title":"First experience with model-based selection of head and neck cancer patients for proton therapy","volume":"151","author":"Tambas","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.14338\/IJPT-21-00042.1_bib42","unstructured":"Rapporten. Dutch Association for Radiotherapy and Oncology. Accessed July 9, 2021, https:\/\/nvro.nl\/publicaties\/rapporten."},{"key":"10.14338\/IJPT-21-00042.1_bib43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.radonc.2019.09.017","article-title":"Cross-modality applicability of rectal normal tissue complication probability models from photon- to proton-based radiotherapy","volume":"142","author":"Pedersen","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.14338\/IJPT-21-00042.1_bib44","doi-asserted-by":"crossref","unstructured":"Marteinsdottir M, Paganetti H., Applying a variable relative biological effectiveness (RBE) might affect the analysis of clinical trials comparing photon and proton therapy for prostate cancer, Phys Med Biol.2019, Jun, 5;64, (11):115027doi:10.1088\/1361-6560\/ab2144.","DOI":"10.1088\/1361-6560\/ab2144"},{"key":"10.14338\/IJPT-21-00042.1_bib45","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration","volume":"162","author":"Moons","year":"2015","journal-title":"Ann Intern Med"}],"container-title":["International Journal of Particle Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518023002287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518023002287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/theijpt\/article-pdf\/9\/1\/42\/3077926\/i2331-5180-9-1-42.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/theijpt\/article-pdf\/9\/1\/42\/3077926\/i2331-5180-9-1-42.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:34:17Z","timestamp":1762421657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2331518023002287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2331518023002287"],"URL":"https:\/\/doi.org\/10.14338\/ijpt-21-00042.1","relation":{},"ISSN":["2331-5180"],"issn-type":[{"value":"2331-5180","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Estimated Late Toxicities between IMPT and IMRT Based on Multivariable NTCP Models for High-Risk Prostate Cancers Treated with Pelvic Nodal Radiation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Particle Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14338\/IJPT-21-00042.1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 \u00a9 2022 THE AUTHORS. Published by Elsevier BV on behalf of the Particle Therapy Co-operative Group. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}